Latest Breaking News On - S kpti us48576u1060 - Page 1 : comparemela.com

– Relapsed/Refractory MDS Patients Achieved Median Overall Survival of 8.7 months – –  Historically, Median Overall Survival in this Hard to Treat Patient Population is Only. | May 3, 2023

United statesUnited kingdomReshma rangwalaSelective inhibitor of nuclear exportPrnewswire karyopharm therapeutics incDrug administrationInternational congress on myelodysplastic syndromesKaryopharm therapeutics incExchange commissionAchieved median overall survivalMedian overall survivalTreat patient populationResults indicate potential single agent activityInternational congressMyelodysplastic syndromesChief medical officer